Back

Reducing residual risk in left ventricular assist device carriers: lessons from ARIES-HM3 trial

30 August 2024 (14:00 - 14:15)
Organised by: Logo
Congress Presentation Part of: Showcasing successes in advanced heart failure Clinical ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Mandeep Mehra

Mass General Brigham Heart and Vascular Institute, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Temporary mechanical circulatory support as a bridge to transplant: what have we learned from the ASIS-TC registry?
Doctor E. Barge Caballero (A Coruna, ES)
Slides Video
Presentation thumbnail
Real-world data on patients with left ventricular assist devices: the ELEVATE Registry
Professor F. Gustafsson (Pleasanton, US)
Slides Video
Presentation thumbnail
Update on heart transplantation
Doctor M. Farrero Torres (Barcelona, ES)
Slides Video
Presentation thumbnail
Showcasing successes in advanced heart failure - discussion
Video

Access the full session

Session thumbnail
Showcasing successes in advanced heart failure
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Aspirin and hemocompatibility related adverse events after LVAD implantation in patients with diabetes mellitus, obesity and atrial fibrillation: the ARIES-HM3 randomized clinical trial
thumbnail
Congress Presentation
Outcomes with aspirin avoidance after implantation of a Fully Magnetically Levitated LVAD in patients with coronary, cerebral or peripheral vascular disease: the ARIES HM3 randomized clinical trial
thumbnail
Congress Presentation
Discussant review - ARIES

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources